The TUBB1 Q43P functional polymorphism reduces the risk of cardiovascular disease in men by modulating platelet function and structure

Blood

Volumn 106, Issue 7, 2005, Pages 2356-2362

  Freson, Kathleen ^a   De Vos, Rita ^b   Wittevrongel, Christine ^b   Thys, Chantal ^b   Defoor, Johan ^b   Vanhees, Luc ^b   Vermylen, Jos ^b   Peerlinck, Kathelijne ^b   Van Geet, Chris ^b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA TUBULIN; COLLAGEN; GREEN FLUORESCENT PROTEIN; THROMBIN RECEPTOR ACTIVATING PEPTIDE;

ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DNA POLYMORPHISM; ELECTRON MICROSCOPY; FEMALE; HETEROZYGOTE; HUMAN; MALE; MEGAKARYOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL ANALYSIS; SUBSTITUTION REACTION; THROMBOCYTE; THROMBOCYTE FUNCTION; THROMBOCYTE STRUCTURE;

EID: 27144501822     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2005-02-0723     Document Type: Article

References (27)

1. Sullivan KF. Structure and utilization of tubulin isotypes. Annu Rev Cell Biol. 1988;4:687-716.
2. ClevelandDW. The multitubulin hypothesis revisited: what have we learned? J Cell Biol. 1987;104:381-383.
3. Luduena RF. Multiple forms of tubulin: different gene products and covalent modifications. Int Rev Cytol. 1998;178:207-275.
4. Luduena RF. Are tubulin isotypes functionally significant? Mol Biol Cell. 1993;4:445-457.
5. Wang D, Villasante A, Lewis SA, Cowan NJ. The mammalian beta-tubulin repertoire: hematopoietic expression of a novel, heterologous betatubulin isotype. J Cell Biol. 1986;103:1903-1910.
6. Lecine P, Italiano JE Jr, Kim SW, Villeval JL, Shivdasani RA. Hematopoietic-specific beta 1 tubulin participates in a pathway of platelet biogenesis dependent on the transcription factor NF-E2. Blood. 2000;96:1366-1373.
7. Schwer HD, Lecine P, Tiwari S, Italiano JE Jr, Hartwig JH, Shivdasani RA. A lineage-restricted and divergent beta-tubulin isoform is essential for the biogenesis, structure and function of blood platelets. Curr Biol. 2001;11:579-586.
8. Radley JM, Hartshorn MA. Megakaryocyte fragments and the microtubule coil. Blood Cells. 1987;12:603-614.
9. Italiano JE Jr, Lecine P, Shivdasani RA, Hartwig JH. Blood platelets are assembled principally at the ends of proplatelet processes produ120 ced by differentiated megakaryocytes. J Cell Biol. 1999;147:1299-1312.
10. Italiano JE Jr, Bergmeier W, Tiwari S, et al. Mechanisms and implications of platelet discoid shape. Blood. 2003;101:4789-4796.
11. Freson K, Devriendt K, Matthijs G, et al. Platelet characteristics in patients with X-linked macrothrombocytopenia because of a novel GATA1 mutation. Blood. 2001;98:85-92.
12. Lewis SA, GuW, Cowan NJ. Free intermingling of mammalian beta-tubulin isotypes among functionally distinct microtubules. Cell. 1987;49:539-548.
13. Theilmeier G, Lenaerts T, Remacle C, Collen D, Vermylen J, Hoylaerts MF. Circulating activated platelets assist THP-1 monocytoid/endothelial cell interaction under shear stress. Blood. 1999;94:2725-2734.
14. Savoia A, Balduini CL, Savino M, et al. Autosomal dominant macrothrombocytopenia in Italy is most frequently a type of heterozygous Bernard-Soulier syndrome. Blood. 2001;97:1330-1335.
15. Paul BZ, Kim S, Dangelmaier C, et al Dynamic regulation of microtubule coils in ADP-induced platelet shape change by p160ROCK (Rho-kinase). Platelets. 2003;14:159-169.
16. Cerecedo D, Stock R, Gonzalez S, Reyes E, Mondragon R. Modification of actin, myosin and tubulin distribution during cytoplasmic granule movements associated with platelet adhesion. Haematologica. 2002;87:1165-1176.
17. Smith NG, Webster MT, Ellegren H. A low rate of simultaneous double-nucleotide mutations in primates. Mol Biol Evol. 2003;20:47-53.
18. Van Geet C, Freson K, De Vos R, Vermylen J. Hereditary thrombocytopenias. In: Gresele P, Page CP, Fuster V, Vermylen J, eds. Platelets in Thrombotic and Non-Thrombotic Disorders: Pathophysiology, Pharmacology and Therapeutics. Cambridge University Press, Cambridge, United Kingdom; 2002:515-527.
19. Drachman JG. Inherited thrombocytopenia: when a low platelet count does not mean ITP. Blood. 2004;103:390-398.
20. Schulze H, Shivdasani RA. Molecular mechanisms of megakaryocyte differentiation. Semin Thromb Hemost. 2004;30:389-398.
21. White JG, de Alarcon PA. Platelet spherocytosis: a new bleeding disorder. Am J Hematol. 2002;70:158-166.
22. Shivdasani RA, Rosenblatt MF, Zucker-Franklin D, et al. Transcription factor NF-E2 is required for platelet formation independent of the actions of thrombopoietin/MGDF in megakaryocyte development. Cell. 1995;81:695-704.
23. Meisel C, Lopez JA, Stangl K. Role of platelet glycoprotein polymorphisms in cardiovascular diseases. Naunyn Schmiedebergs Arch Pharmacol. 2004;369:38-54.
24. Kunicki TJ, Nugent DJ. The influence of platelet glycoprotein polymorphisms on receptor function and risk for thrombosis. Vox Sang. 2002;83:85-90.
25. Patel H, Rosengren A, Ekman I. Symptoms in acute coronary syndromes: does sex make a difference? Am Heart J. 2004 ;148:27-33.
26. Leinwand LA. Sex is a potent modifier of the cardiovascular system. J Clin Invest. 2003;112:302-307.
27. Devon HA, Zerwic JJ. Symptoms of acute coronary syndromes: are there gender differences?Areview of the literature. Heart Lung. 2002;31:235-245.